Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Post-Treatment Lyme Disease: early-phase trial registry
5 of 5 indexed Post-Treatment Lyme Disease trials are currently recruiting, with more weight in Phase 1-2.
Corpus placement: #3,391 of 28,707 conditions by registered trial count.
5 US clinical trials · 5 currently recruiting · #3,391 of 28,707 conditions by registered trial count
Post-Treatment Lyme Disease: 5 US clinical trials tracked, 5 recruiting.
Post-Treatment Lyme Disease is the subject of 5 registered US clinical trials on ClinicalTrials.gov, 5 of them currently open to new participants. 0 are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most active sponsor is Children's National Research Institute, running 2 of these trials.
Enrollment posture brief
Registry condition post-treatment-lyme-disease
OPEN 5 | RECR 100% | LATE 0 | EARLY 1 | RANK #3391 | SPON 2
Volume-matched condition peers
Nearest open-share peer: Aortic Arch Aneurysm (100% recruiting · 5 trials)
Post-Treatment Lyme Disease lists 5 open slots (100% of 5 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Post-Treatment Lyme Disease on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Post-Treatment Lyme Disease is recruiting above its size-band peers.
5 of 5 indexed trials (100%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
One sponsor concentrates Post-Treatment Lyme Disease research.
Children's National Research Institute accounts for 2 of 5 trials (40%). 3 distinct sponsors appear on at least one study for this condition label.
-
Most Post-Treatment Lyme Disease trials plan to enrol fewer than 100 people.
Median target enrolment is 40 among the 5 trials that report a genuine target (sentinel values excluded). 4 of those (80%) plan for fewer than 100 participants.
-
Post-Treatment Lyme Disease splits between interventional and observational designs.
3 interventional and 2 observational studies make up this index (60% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
5 total, page 1 of 1
Transcranial Direct Current Stimulation for Post Treatment Lyme Disease
Columbia University
NCT06915324
Ceftriaxone Pulse Dose for Post-Treatment Lyme Disease
State University of New York - Upstate Medical University
NCT06611111
Pregnancy and Early Neurodevelopmental Outcomes Following In Utero Lyme Disease Exposure
Children's National Research Institute
NCT06026969
Navigating Pregnancy and Parenthood With Lyme Disease
Children's National Research Institute
NCT06397794
taVNS for Persistent Symptoms From Lyme Disease
Columbia University
NCT05776251
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 1 |
Top Sponsors
Named interventions
Most-linked intervention names on Post-Treatment Lyme Disease records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Post-Treatment Lyme Disease trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Post-Treatment Lyme Disease page
5 registered trials, 5 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 5 Post-Treatment Lyme Disease trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Children's National Research Institute sponsors the most Post-Treatment Lyme Disease trials on record, review their full trial history before evaluating a specific study. See Children's National Research Institute's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Post-Treatment Lyme Disease condition card totals 5 registered trials; most-linked intervention Dextrose 5% (D5W); top US site state New York. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.